Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 259

1.

Sputum transcriptomics implicates increased p38 signalling activity in severe asthma.

Baines KJ, Fricker M, McDonald VM, Simpson JL, Wood LG, Wark PAB, Macdonald HE, Reid A, Gibson PG.

Respirology. 2019 Dec 6. doi: 10.1111/resp.13749. [Epub ahead of print]

PMID:
31808595
2.

Targeting Treatable Traits in Severe Asthma: A Randomised Controlled Trial.

McDonald VM, Clark VL, Cordova-Rivera L, Wark PAB, Baines KJ, Gibson PG.

Eur Respir J. 2019 Dec 5. pii: 1901509. doi: 10.1183/13993003.01509-2019. [Epub ahead of print]

PMID:
31806719
3.

Exacerbations of chronic obstructive pulmonary disease: time to rename.

Bafadhel M, Criner G, Dransfield MT, Janssens W, McDonald VM, Vogelmeier CF, Russell RE, Collis P.

Lancet Respir Med. 2019 Nov 27. pii: S2213-2600(19)30414-X. doi: 10.1016/S2213-2600(19)30414-X. [Epub ahead of print] No abstract available.

PMID:
31786125
4.

Living well with severe asthma.

Stubbs MA, Clark VL, McDonald VM.

Breathe (Sheff). 2019 Jun;15(2):e40-e49. doi: 10.1183/20734735.0165-2019. Review.

5.

Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ.

Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812.

6.

Approaches to the assessment of severe asthma: barriers and strategies.

Majellano EC, Clark VL, Winter NA, Gibson PG, McDonald VM.

J Asthma Allergy. 2019 Aug 23;12:235-251. doi: 10.2147/JAA.S178927. eCollection 2019.

7.

Management of Severe Asthma: a European Respiratory Society/American Thoracic Society Guideline.

Holguin F, Cardet JC, Chung KF, Diver S, Ferreira DS, Fitzpatrick A, Gaga M, Kellermeyer L, Khurana S, Knight S, McDonald VM, Morgan RL, Ortega VE, Rigau D, Subbarao P, Tonia T, Adcock IM, Bleecker ER, Brightling C, Boulet LP, Cabana M, Castro M, Chanez P, Custovic A, Djukanovic R, Frey U, Frankemolle B, Gibson P, Hamerlijnck D, Jarjour N, Konno S, Shen H, Vitary C, Bush A.

Eur Respir J. 2019 Sep 26. pii: 1900588. doi: 10.1183/13993003.00588-2019. [Epub ahead of print]

PMID:
31558662
8.

Does maintenance azithromycin reduce asthma exacerbations? An individual participant data meta-analysis.

Hiles SA, McDonald VM, Guilhermino M, Brusselle GG, Gibson PG.

Eur Respir J. 2019 Nov 28;54(5). pii: 1901381. doi: 10.1183/13993003.01381-2019. Print 2019 Nov.

PMID:
31515407
9.

Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma.

Jones KA, Gibson PG, Yorke J, Niven R, Smith A, McDonald VM.

J Asthma. 2019 Sep 16:1-10. doi: 10.1080/02770903.2019.1665064. [Epub ahead of print]

PMID:
31490698
10.

School-based asthma self-management interventions for children and adolescents with asthma.

Harris K, Kneale D, Lasserson T, McDonald VM, Grigg J, Thomas J.

Paediatr Respir Rev. 2019 Aug;31:40-42. doi: 10.1016/j.prrv.2019.06.005. Epub 2019 Jun 28. Review. No abstract available.

PMID:
31422031
11.

Treatable traits in acute exacerbations of chronic airway diseases.

McDonald VM, Osadnik CR, Gibson PG.

Chron Respir Dis. 2019 Jan-Dec;16:1479973119867954. doi: 10.1177/1479973119867954.

12.

Risk factors of sleep-disordered breathing in haemodialysis patients.

Chu G, Suthers B, Moore L, Paech GM, Hensley MJ, McDonald VM, Choi P.

PLoS One. 2019 Aug 12;14(8):e0220932. doi: 10.1371/journal.pone.0220932. eCollection 2019.

13.

Lactobacillus rescues postnatal neurobehavioral and microglial dysfunction in a model of maternal microbiome dysbiosis.

Lebovitz Y, Kowalski EA, Wang X, Kelly C, Lee M, McDonald V, Ward R, Creasey M, Mills W, Gudenschwager Basso EK, Hazy A, Hrubec T, Theus MH.

Brain Behav Immun. 2019 Oct;81:617-629. doi: 10.1016/j.bbi.2019.07.025. Epub 2019 Jul 24.

PMID:
31351186
14.

Dysregulation of sputum columnar epithelial cells and products in distinct asthma phenotypes.

Qin L, Gibson PG, Simpson JL, Baines KJ, McDonald VM, Wood LG, Powell H, Fricker M.

Clin Exp Allergy. 2019 Nov;49(11):1418-1428. doi: 10.1111/cea.13452. Epub 2019 Aug 6.

PMID:
31264263
15.

Extrapulmonary associations of health status in severe asthma and bronchiectasis: Comorbidities and functional outcomes.

Cordova-Rivera L, Gibson PG, Gardiner PA, Hiles SA, McDonald VM.

Respir Med. 2019 Jul - Aug;154:93-101. doi: 10.1016/j.rmed.2019.06.010. Epub 2019 Jun 13.

PMID:
31229944
16.

Treatable traits and their application in high-, middle- and low-income countries.

McDonald VM, Gibson PG.

Respirology. 2019 Oct;24(10):942-943. doi: 10.1111/resp.13626. Epub 2019 Jun 20. No abstract available.

17.

Treatable traits: a new paradigm for 21st century management of chronic airway diseases: Treatable Traits Down Under International Workshop report.

McDonald VM, Fingleton J, Agusti A, Hiles SA, Clark VL, Holland AE, Marks GB, Bardin PP, Beasley R, Pavord ID, Wark PAB, Gibson PG; participants of the Treatable Traits Down Under International Workshop; Treatable Traits Down Under International Workshop participants:.

Eur Respir J. 2019 May 9;53(5). pii: 1802058. doi: 10.1183/13993003.02058-2018. Print 2019 May. Review.

PMID:
30846468
18.

Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.

Doobaree IU, Newland A, McDonald V, Nandigam R, Mensah L, Leroy S, Seesaghur A, Patel H, Wetten S, Provan D.

Eur J Haematol. 2019 May;102(5):416-423. doi: 10.1111/ejh.13221. Epub 2019 Mar 7.

19.

School-based self-management interventions for asthma in children and adolescents: a mixed methods systematic review.

Harris K, Kneale D, Lasserson TJ, McDonald VM, Grigg J, Thomas J.

Cochrane Database Syst Rev. 2019 Jan 28;1:CD011651. doi: 10.1002/14651858.CD011651.pub2.

PMID:
30687940
20.

Effectiveness of school-based self-management interventions for asthma among children and adolescents: findings from a Cochrane systematic review and meta-analysis.

Kneale D, Harris K, McDonald VM, Thomas J, Grigg J.

Thorax. 2019 May;74(5):432-438. doi: 10.1136/thoraxjnl-2018-211909. Epub 2019 Jan 27.

PMID:
30686788
21.

Managing patients with severe asthma in Australia: Current challenges with the existing models of care.

Chung LP, Hew M, Bardin P, McDonald VM, Upham JW.

Intern Med J. 2018 Dec;48(12):1536-1541. doi: 10.1111/imj.14103.

PMID:
30517993
22.

Health-related quality of life burden in severe asthma.

McDonald VM, Hiles SA, Jones KA, Clark VL, Yorke J.

Med J Aust. 2018 Jul 16;209(S2):S28-S33.

PMID:
30453870
23.

Physical activity associates with disease characteristics of severe asthma, bronchiectasis and COPD.

Cordova-Rivera L, Gibson PG, Gardiner PA, McDonald VM.

Respirology. 2019 Apr;24(4):352-360. doi: 10.1111/resp.13428. Epub 2018 Nov 1.

PMID:
30384396
24.

Nebulised hypertonic saline for cystic fibrosis.

Wark P, McDonald VM.

Cochrane Database Syst Rev. 2018 Sep 27;9:CD001506. doi: 10.1002/14651858.CD001506.pub4. Review.

25.

Treatable traits can be identified in a severe asthma registry and predict future exacerbations.

McDonald VM, Hiles SA, Godbout K, Harvey ES, Marks GB, Hew M, Peters M, Bardin PG, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Lara Rivero A, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PAB, Yang IA, Yap E, Gibson PG.

Respirology. 2019 Jan;24(1):37-47. doi: 10.1111/resp.13389. Epub 2018 Sep 19.

26.

Ageing well in a foreign land as a process of successful social identity change.

Jetten J, Dane S, Williams E, Liu S, Haslam C, Gallois C, McDonald V.

Int J Qual Stud Health Well-being. 2018 Dec;13(1):1508198. doi: 10.1080/17482631.2018.1508198.

27.

The utility of a fast turnaround ADAMTS13 activity in the diagnosis and exclusion of thrombotic thrombocytopenic purpura.

Thomas W, Cutler JA, Moore GW, McDonald V, Hunt BJ.

Br J Haematol. 2019 Mar;184(6):1026-1032. doi: 10.1111/bjh.15219. Epub 2018 Apr 24. No abstract available.

PMID:
29687882
28.

Working while unwell: Workplace impairment in people with severe asthma.

Hiles SA, Harvey ES, McDonald VM, Peters M, Bardin P, Reynolds PN, Upham JW, Baraket M, Bhikoo Z, Bowden J, Brockway B, Chung LP, Cochrane B, Foxley G, Garrett J, Hew M, Jayaram L, Jenkins C, Katelaris C, Katsoulotos G, Koh MS, Kritikos V, Lambert M, Langton D, Lara Rivero A, Marks GB, Middleton PG, Nanguzgambo A, Radhakrishna N, Reddel H, Rimmer J, Southcott AM, Sutherland M, Thien F, Wark PAB, Yang IA, Yap E, Gibson PG.

Clin Exp Allergy. 2018 Jun;48(6):650-662. doi: 10.1111/cea.13153. Epub 2018 May 17.

PMID:
29676834
29.

More on Ofatumumab for TTP.

Crowley MP, McDonald V, Scully M.

N Engl J Med. 2018 Apr 5;378(14):1365. doi: 10.1056/NEJMc1801263. No abstract available.

PMID:
29617588
30.

A Systematic Review of Associations of Physical Activity and Sedentary Time with Asthma Outcomes.

Cordova-Rivera L, Gibson PG, Gardiner PA, McDonald VM.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):1968-1981.e2. doi: 10.1016/j.jaip.2018.02.027. Epub 2018 Mar 3.

PMID:
29510231
31.

Severe asthma: We can fix it? We can try!

McDonald VM, Maltby S, Gibson PG.

Respirology. 2018 Mar;23(3):260-261. doi: 10.1111/resp.13249. Epub 2018 Jan 5. No abstract available.

32.

Ofatumumab for TTP in a Patient with Anaphylaxis Associated with Rituximab.

Crowley MP, McDonald V, Scully M.

N Engl J Med. 2018 Jan 4;378(1):92-93. No abstract available.

PMID:
29298144
33.

Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens.

Westwood JP, Thomas M, Alwan F, McDonald V, Benjamin S, Lester WA, Lowe GC, Dutt T, Hill QA, Scully M.

Blood Adv. 2017 Jun 26;1(15):1159-1166. doi: 10.1182/bloodadvances.2017008268. eCollection 2017 Jun 27.

34.

Adherence in severe asthma: time to get it right.

McDonald VM, Yorke J.

Eur Respir J. 2017 Dec 21;50(6). pii: 1702191. doi: 10.1183/13993003.02191-2017. Print 2017 Dec. No abstract available.

35.

Physical Activity and Exercise Capacity in Severe Asthma: Key Clinical Associations.

Cordova-Rivera L, Gibson PG, Gardiner PA, Powell H, McDonald VM.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):814-822. doi: 10.1016/j.jaip.2017.09.022. Epub 2017 Nov 10.

PMID:
29133222
36.

COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.

Yang IA, Brown JL, George J, Jenkins S, McDonald CF, McDonald VM, Phillips K, Smith BJ, Zwar NA, Dabscheck E.

Med J Aust. 2017 Nov 20;207(10):436-442.

PMID:
29129177
37.

Multiple centre evaluation study of ADAMTS13 activity and inhibitor assays.

Langley K, Fretwell R, Kitchen S, MacDonald S, Dutt T, Baker P, Singh D, McDonald V, Hughes C, Murphy P, Scully M.

Int J Lab Hematol. 2018 Feb;40(1):21-25. doi: 10.1111/ijlh.12718. Epub 2017 Nov 6.

PMID:
29106071
38.

Validation of the patient-completed asthma knowledge questionnaire (PAKQ).

Beaurivage D, Boulet LP, Foster JM, Gibson PG, McDonald VM.

J Asthma. 2018 Feb;55(2):169-179. doi: 10.1080/02770903.2017.1318914. Epub 2017 Oct 26.

PMID:
29072971
39.

Treatment burden, clinical outcomes, and comorbidities in COPD: an examination of the utility of medication regimen complexity index in COPD.

Negewo NA, Gibson PG, Wark PA, Simpson JL, McDonald VM.

Int J Chron Obstruct Pulmon Dis. 2017 Oct 6;12:2929-2942. doi: 10.2147/COPD.S136256. eCollection 2017.

40.

The Impact of a Weight Loss Intervention on Diet Quality and Eating Behaviours in People with Obesity and COPD.

McLoughlin RF, McDonald VM, Gibson PG, Scott HA, Hensley MJ, MacDonald-Wicks L, Wood LG.

Nutrients. 2017 Oct 20;9(10). pii: E1147. doi: 10.3390/nu9101147.

41.

Precision medicine in airway diseases: moving to clinical practice.

Agustí A, Bafadhel M, Beasley R, Bel EH, Faner R, Gibson PG, Louis R, McDonald VM, Sterk PJ, Thomas M, Vogelmeier C, Pavord ID; on behalf of all participants in the seminar.

Eur Respir J. 2017 Oct 19;50(4). pii: 1701655. doi: 10.1183/13993003.01655-2017. Print 2017 Oct.

42.

Fostamatinib for persistent/chronic adult immune thrombocytopenia.

Newland A, Lee EJ, McDonald V, Bussel JB.

Immunotherapy. 2018 Jan;10(1):9-25. doi: 10.2217/imt-2017-0097. Epub 2017 Oct 2. Review.

43.

"I have lost in every facet of my life": the hidden burden of severe asthma.

Foster JM, McDonald VM, Guo M, Reddel HK.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700765. doi: 10.1183/13993003.00765-2017. Print 2017 Sep.

44.

Multidimensional assessment of severe asthma: A systematic review and meta-analysis.

Clark VL, Gibson PG, Genn G, Hiles SA, Pavord ID, McDonald VM.

Respirology. 2017 Oct;22(7):1262-1275. doi: 10.1111/resp.13134. Epub 2017 Aug 3. Review.

45.

Sleep disturbance and sleep-disordered breathing in hemodialysis patients.

Chu G, Choi P, McDonald VM.

Semin Dial. 2018 Jan;31(1):48-58. doi: 10.1111/sdi.12617. Epub 2017 Jun 13. Review.

PMID:
28608937
46.

Management of severe asthma: targeting the airways, comorbidities and risk factors.

Gibson PG, McDonald VM.

Intern Med J. 2017 Jun;47(6):623-631. doi: 10.1111/imj.13441. Review.

PMID:
28580744
47.

Presenting ADAMTS13 antibody and antigen levels predict prognosis in immune-mediated thrombotic thrombocytopenic purpura.

Alwan F, Vendramin C, Vanhoorelbeke K, Langley K, McDonald V, Austin S, Clark A, Lester W, Gooding R, Biss T, Dutt T, Cooper N, Chapman O, Cranfield T, Douglas K, Watson HG, van Veen JJ, Sibson K, Thomas W, Manson L, Hill QA, Benjamin S, Ellis D, Westwood JP, Thomas M, Scully M.

Blood. 2017 Jul 27;130(4):466-471. doi: 10.1182/blood-2016-12-758656. Epub 2017 Jun 2.

PMID:
28576877
48.

"To define is to limit": perspectives on asthma-COPD overlap syndrome and personalised medicine.

McDonald VM, Gibson PG.

Eur Respir J. 2017 May 1;49(5). pii: 1700336. doi: 10.1183/13993003.00336-2017. Print 2017 May. No abstract available.

49.

Australian and New Zealand Pulmonary Rehabilitation Guidelines.

Alison JA, McKeough ZJ, Johnston K, McNamara RJ, Spencer LM, Jenkins SC, Hill CJ, McDonald VM, Frith P, Cafarella P, Brooke M, Cameron-Tucker HL, Candy S, Cecins N, Chan AS, Dale MT, Dowman LM, Granger C, Halloran S, Jung P, Lee AL, Leung R, Matulick T, Osadnik C, Roberts M, Walsh J, Wootton S, Holland AE; Lung Foundation Australia and the Thoracic Society of Australia and New Zealand.

Respirology. 2017 May;22(4):800-819. doi: 10.1111/resp.13025. Epub 2017 Mar 24.

PMID:
28339144
50.

Airway gene expression of IL-1 pathway mediators predicts exacerbation risk in obstructive airway disease.

Baines KJ, Fu JJ, McDonald VM, Gibson PG.

Int J Chron Obstruct Pulmon Dis. 2017 Feb 8;12:541-550. doi: 10.2147/COPD.S119443. eCollection 2017.

Supplemental Content

Loading ...
Support Center